Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency
Status:
Completed
Trial end date:
2021-07-28
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to determine the safety and efficacy and to generate PK
and biomarker data for the combination of Pomalidomide and low-dose Dexamethasone in patients
with relapsed or refractory multiple myeloma, with moderate or severe renal impairment.